Updates on Surgical Oncology1
The value of multidiciplinary cancer care and research: the role of the surgeon as an oncologist and clinical investigator
Chinese Clinical Oncology
2014;
3
(4)
:42
.
(01 December 2014)
Organizing a multidisciplinary clinic
Chinese Clinical Oncology
2014;
3
(4)
:43
.
(01 December 2014)
The distinctive features of surgical oncology as a specialty: considerations for Chinese surgeons
Chinese Clinical Oncology
2014;
3
(4)
:44
.
(01 December 2014)
Training and certification of the surgical oncologist
Chinese Clinical Oncology
2014;
3
(4)
:45
.
(01 December 2014)
Clinical trials in lung cancer surgery and research cooperation
Chinese Clinical Oncology
2014;
3
(4)
:46
.
(01 December 2014)
Original Article
Analysis of cardiac adverse events following postmastectomy hypofractionated radiotherapy
Chinese Clinical Oncology
2014;
3
(4)
:47
.
(01 December 2014)
Statistics in Oncology Clinical Trials2
Phase II design: history and evolution
Chinese Clinical Oncology
2014;
3
(4)
:48
.
(01 December 2014)
Adaptive clinical trial designs in oncology
Chinese Clinical Oncology
2014;
3
(4)
:49
.
(01 December 2014)
Meet the Professor3
Professor Bruce D. Minsky: Advances in radiation oncology in 2014 ASTRO
Chinese Clinical Oncology
2014;
3
(4)
:50
.
(01 December 2014)
Professor Hope S. Rugo: Reversing resistance and hormone therapy for metastatic breast cancer
Chinese Clinical Oncology
2014;
3
(4)
:51
.
(01 December 2014)
Prof. Yi-Long Wu: Patients on the afatinib arm had a significantly better quality of life according to the data of LUX-Lung 6
Chinese Clinical Oncology
2014;
3
(4)
:52
.
(01 December 2014)
Your Views
Widespread use of pemetrexed in oncology: has it turned it into a new drug?
Chinese Clinical Oncology
2014;
3
(4)
:53
.
(01 December 2014)
Disclosure:
1. The series “Updates on Surgical Oncology” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Charles M. Balch served as the unpaid Guest Editor for the series.
2. The series “Statistics in Oncology Clinical Trials” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Daniel J. Sargent and Qian Shi served as the unpaid Guest Editors for the series.
3. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.